
Zachariah Lucas
Supervisory Patent Examiner (ID: 15977, Phone: (571)272-0905 , Office: P/1600 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1600, 1648 |
| Total Applications | 707 |
| Issued Applications | 248 |
| Pending Applications | 93 |
| Abandoned Applications | 367 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5040616
[patent_doc_number] => 20070092898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-26
[patent_title] => 'Detection of multiple anti-viral antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/504510
[patent_app_country] => US
[patent_app_date] => 2006-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12380
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20070092898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11504510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/504510 | Detection of multiple anti-viral antibodies | Aug 14, 2006 | Abandoned |
Array
(
[id] => 5171744
[patent_doc_number] => 20070072176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/503245
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 35072
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20070072176.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503245
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503245 | Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus | Aug 10, 2006 | Abandoned |
Array
(
[id] => 5051420
[patent_doc_number] => 20070031965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Anti-pathogen treatments'
[patent_app_type] => utility
[patent_app_number] => 11/503416
[patent_app_country] => US
[patent_app_date] => 2006-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 87
[patent_figures_cnt] => 87
[patent_no_of_words] => 93393
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11503416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/503416 | Anti-pathogen treatments | Aug 10, 2006 | Issued |
Array
(
[id] => 285639
[patent_doc_number] => 07550566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'G-CSF conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/463863
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37996
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550566.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463863 | G-CSF conjugates | Aug 9, 2006 | Issued |
Array
(
[id] => 285638
[patent_doc_number] => 07550565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-23
[patent_title] => 'G-CSF conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/463861
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37952
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/550/07550565.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463861
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463861 | G-CSF conjugates | Aug 9, 2006 | Issued |
Array
(
[id] => 5687754
[patent_doc_number] => 20060286069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'G-CSF Conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/463867
[patent_app_country] => US
[patent_app_date] => 2006-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 37966
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286069.pdf
[firstpage_image] =>[orig_patent_app_number] => 11463867
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/463867 | G-CSF conjugates | Aug 9, 2006 | Issued |
Array
(
[id] => 5609313
[patent_doc_number] => 20060270829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'G-CSF CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 11/462335
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35614
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11462335
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/462335 | G-CSF CONJUGATES | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5142688
[patent_doc_number] => 20070004904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'G-CSF CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 11/462354
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35623
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004904.pdf
[firstpage_image] =>[orig_patent_app_number] => 11462354
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/462354 | G-CSF CONJUGATES | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5080472
[patent_doc_number] => 20070123696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'G-CSF CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 11/462331
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35687
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20070123696.pdf
[firstpage_image] =>[orig_patent_app_number] => 11462331
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/462331 | G-CSF CONJUGATES | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5296038
[patent_doc_number] => 20090010964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/794503
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11589
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20090010964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794503 | Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5609187
[patent_doc_number] => 20060270703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'G-CSF CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 11/462353
[patent_app_country] => US
[patent_app_date] => 2006-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35608
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270703.pdf
[firstpage_image] =>[orig_patent_app_number] => 11462353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/462353 | G-CSF CONJUGATES | Aug 2, 2006 | Abandoned |
Array
(
[id] => 5887521
[patent_doc_number] => 20060275257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'G-CSF Conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/462037
[patent_app_country] => US
[patent_app_date] => 2006-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31731
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11462037
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/462037 | G-CSF Conjugates | Aug 1, 2006 | Abandoned |
Array
(
[id] => 5661496
[patent_doc_number] => 20060252092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same'
[patent_app_type] => utility
[patent_app_number] => 11/486885
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4605
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252092.pdf
[firstpage_image] =>[orig_patent_app_number] => 11486885
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/486885 | Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same | Jul 13, 2006 | Issued |
Array
(
[id] => 5732248
[patent_doc_number] => 20060257365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 11/478879
[patent_app_country] => US
[patent_app_date] => 2006-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6232
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20060257365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11478879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/478879 | Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection | Jun 29, 2006 | Abandoned |
Array
(
[id] => 5034757
[patent_doc_number] => 20070099296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs'
[patent_app_type] => utility
[patent_app_number] => 11/453578
[patent_app_country] => US
[patent_app_date] => 2006-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26593
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099296.pdf
[firstpage_image] =>[orig_patent_app_number] => 11453578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/453578 | Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs | Jun 13, 2006 | Abandoned |
Array
(
[id] => 5625315
[patent_doc_number] => 20060263820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins'
[patent_app_type] => utility
[patent_app_number] => 11/449829
[patent_app_country] => US
[patent_app_date] => 2006-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7150
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11449829
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/449829 | Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins | Jun 8, 2006 | Issued |
Array
(
[id] => 5563663
[patent_doc_number] => 20090136515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Methods of diagnosing, preventing and treating infection with Hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/921285
[patent_app_country] => US
[patent_app_date] => 2006-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 10811
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136515.pdf
[firstpage_image] =>[orig_patent_app_number] => 11921285
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/921285 | Methods of diagnosing, preventing and treating infection with Hepatitis C virus | Jun 1, 2006 | Abandoned |
Array
(
[id] => 5188015
[patent_doc_number] => 20070166323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Yeast-dendritic cell vaccines and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/446597
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20187
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20070166323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11446597
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/446597 | Yeast-antigen compositions methods of making the same | May 31, 2006 | Issued |
Array
(
[id] => 4443897
[patent_doc_number] => 07862821
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Recombinant vaccine against bluetongue virus'
[patent_app_type] => utility
[patent_app_number] => 11/444698
[patent_app_country] => US
[patent_app_date] => 2006-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 21
[patent_no_of_words] => 28352
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/862/07862821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11444698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/444698 | Recombinant vaccine against bluetongue virus | May 31, 2006 | Issued |
Array
(
[id] => 5890410
[patent_doc_number] => 20060276622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM'
[patent_app_type] => utility
[patent_app_number] => 11/419528
[patent_app_country] => US
[patent_app_date] => 2006-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 28660
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276622.pdf
[firstpage_image] =>[orig_patent_app_number] => 11419528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/419528 | PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES, A PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM | May 21, 2006 | Abandoned |